![]() |
![]() |
(17β)-Oxandrolone (4aS,4bS,6aS,7S,9aS,9bR,11aS)-Tetradecahydro-7-hydroxy-4a,6a,7-trimethylcyclopenta[5,6]naphtho[1,2-c]pyran-2(1H)-one 17b-Hydroxy-17a-methyl-2-oxa-5a-androstan-3-one 17b-Hydroxy-17-methyl-2-oxa-5a-androstan-3-one 17-Methyl-2-oxa-5a-androstan-17b-ol-3-one 17-Methyl-2-oxa-5α-androstan-17β-ol-3-one 17β-Hydroxy-17-methyl-2-oxa-5α-androstan-3-one 17β-Hydroxy-17α-methyl-2-oxa-5α-androstan-3-one 2-Oxa-5a-androstan-3-one, 17b-hydroxy-17-methyl- (7CI,8CI) 2-Oxa-5α-androstan-3-one, 17β-hydroxy-17-methyl- 2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5a,17b)- 2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5α,17β)- 8075CB Anavar Cyclopenta[5,6]naphtho[1,2-c]pyran-2(1H)-one, tetradecahydro-7-hydroxy-4a,6a,7-trimethyl-, (4aS,4bS,6aS,7S,9aS,9bR,11aS)- Lonavar NSC 67068 Oxandren Oxandrin Protivar Provitar SC 11585 SC11585 Vasorome
The Oxandrolone is male hormone with the major role protein assimilation. It is used in the treatment of high cholesterol and triglyceride disorders. The IUPAC name of this chemical is (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one. With the CAS registry number 53-39-4, it is also named as 17beta-Hydroxy-17-methyl-2-oxa-5alpha-androstan-3-one. The product's categories are miscellaneous; biochemistry; steroids. Additionally, Oxandrolone is toxic and flammable. It will produce irritative smoke when buring. So the storage environment should be ventilate, low-temperature and dry. This chemical is odorless and white crystalline powder which is soluble in chloroform, slightly soluble in ethanol, acetone, ether, and very slightly soluble in water. Furthermore, Oxandrolone can be obtained by 5-androstane-1-en-3-17-dione or 17β-Hydroxy-17-α-methyl derivatives.
The other characteristics of this product can be summarized as:?(1)ACD/LogP: 3.33; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 3.33; (4)ACD/LogD (pH 7.4): 3.33; (5)ACD/BCF (pH 5.5): 199.84; (6)ACD/BCF (pH 7.4): 199.84; (7)ACD/KOC (pH 5.5): 1543.23; (8)ACD/KOC (pH 7.4): 1543.23; (9)#H bond acceptors: 3; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 1; (12)Index of Refraction: 1.526; (13)Molar Refractivity: 85.1 cm3; (14)Molar Volume: 277 cm3; (15)Polarizability: 33.73×10-24 cm3; (16)Surface Tension: 39.8 dyne/cm; (17)Enthalpy of Vaporization: 81.03 kJ/mol; (18)Vapour Pressure: 9.19E-10 mmHg at 25°C; (19)Tautomer Count: 2; (20)Exact Mass: 306.219495; (21)MonoIsotopic Mass: 306.219495; (22)Topological Polar Surface Area: 46.5; (23)Heavy Atom Count: 22; (24)Complexity: 503.
People can use the following data to convert to the molecule structure.
1. SMILES:O=C3OC[C@@]2([C@H]1CC[C@@]4(C)[C@H]([C@@H]1CC[C@H]2C3)CC[C@@]4(O)C)C?
2. InChI:InChI=1/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3/t12-,13+,14-,15-,17-,18-,19-/m0/s1
The following are the toxicity data which has been tested.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
man | TDLo | oral | 2400ug/kg/2W- (2.4mg/kg) | BEHAVIORAL: EUPHORIA BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: IRRITABILITY |
Journal of Clinical Psychiatry. Vol. 46, Pg. 354, 1985. |
mouse | LD50 | intraperitoneal | 922mg/kg (922mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. ? |
mouse | LD50 | oral | 1832mg/kg (1832mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. ? |
mouse | LD50 | subcutaneous | > 11gm/kg (11000mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. |
rabbit | LD50 | oral | > 5gm/kg (5000mg/kg) | ? | Drugs in Japan Vol. 6, Pg. 149, 1982. |
rat | LD50 | intraperitoneal | 4893mg/kg (4893mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: TREMOR |
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. ? |
rat | LD50 | oral | > 10gm/kg (10000mg/kg) | ? | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. |
rat | LD50 | subcutaneous | > 10gm/kg (10000mg/kg) | ? | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 65, Pg. 418, 1969. |
Acute toxicity - Dermal, Category 4
Acute toxicity - Inhalation, Category 4
Reproductive toxicity, Category 1B
Pictogram(s) | ![]() ![]() |
---|---|
Signal word | Danger |
Hazard statement(s) | H312 Harmful in contact with skin H332 Harmful if inhaled H360 May damage fertility or the unborn child |
Precautionary statement(s) | |
Prevention | P280 Wear protective gloves/protective clothing/eye protection/face protection. P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P271 Use only outdoors or in a well-ventilated area. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. |
Response | P302+P352 IF ON SKIN: Wash with plenty of water/... P312 Call a POISON CENTER/doctor/\u2026if you feel unwell. P321 Specific treatment (see ... on this label). P362+P364 Take off contaminated clothing and wash it before reuse. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P308+P313 IF exposed or concerned: Get medical advice/ attention. |
Storage | P405 Store locked up. |
Disposal | P501 Dispose of contents/container to ... |
none